Inflammation as the primary aetiological agent of human prostate cancer: A stem cell connection?
Corresponding Author
Norman J. Maitland
YCR Cancer Research Unit, Deparment of Biology, University of York, York YO10 5YW, United Kingdom
University of York, Heslington, York Y010 5YW, United Kingdom.Search for more papers by this authorAnne T. Collins
YCR Cancer Research Unit, Deparment of Biology, University of York, York YO10 5YW, United Kingdom
Search for more papers by this authorCorresponding Author
Norman J. Maitland
YCR Cancer Research Unit, Deparment of Biology, University of York, York YO10 5YW, United Kingdom
University of York, Heslington, York Y010 5YW, United Kingdom.Search for more papers by this authorAnne T. Collins
YCR Cancer Research Unit, Deparment of Biology, University of York, York YO10 5YW, United Kingdom
Search for more papers by this authorAbstract
Inflammation has been implicated for some time as a potential aetiological agent in human prostate cancer. Viral and bacterial infections or even chemical carcinogens such as those found in cooked meat have been proposed as the inflammatory stimuli, but the mechanism of cancer induction is unknown. Recent information about gene expression patterns in normal and malignant epithelial stem cells from human prostate provides a new hypothesis for inflammation-induced carcinogenesis. The hypothesis states that in the stem cells located in the basal cell compartment of the prostate, activated prostate epithelial stem cells acquire a survival advantage, by expressing one of more of the same cytokines such as IL6. The establishment of one or more autocrine signalling loops results in an expansion of these cells in the absence of inflammation, as a potential first stage in the development of the tumour. J. Cell. Biochem. 105: 931–939, 2008. © 2008 Wiley-Liss, Inc.
REFERENCES
- Abate-Shen C, Shen MM. 2000. Molecular genetics of prostate cancer. Genes Dev 14: 2410–2434.
- Adams MD, Kerlavage AR, Fleischmann RD, Fuldner RA, Bult CJ, Lee NH, Kirkness EF, Weinstock KG, Gocayne JD, White O, Sutton G, Blake JA, Brandon RC, Chiu M-W, Clayton RA, Cline RT, Cotton MD, Earle-Hughes J, Fine LD, Fitzgerald LM, Fitzhugh WM, Fritchman JL, Geoghagen NSM, Glodek A, Gnehm CL, Hanna MC, Hedblom E, Hinkle PS Jr, Kelley JM, Klimek KM, Kelley JC, Liu L-I, Marmaros SM, Merrick JM, Moreno-Palanques RF, McDonald LA, Nguyen DT, Pellegrino SM, Phillips CA, Ryder SE, Scott JL, Saudek DM, Shirley R, Small KV, Spriggs TA, Utterback TR, Weidman JF, Li Y, Barthlow R, Bednarik DP, Cao L, Cepeda MA, Coleman TA, Collins E-J, Dimke D, Feng P, Ferrie A, Fischer C, Hastings GA, He W-W, Hu J-S, Huddleston KA, Greene JM, Gruber J, Hudson P, Kim A, Kozak DL, Kunsch C, Gi H, Li H, Meissner PS, Olsen H, Raymond L, Wei J-F, Wing J, Xu C, Yu G-L, Ruben SM, Dillon PJ, Fannon MR, Rosen CA, Haseltine WA, Fields C, Fraser CM, Venter JC. 1995. Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence. Nature 377(6547 Suppl): 3–174.
- Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. 2003. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci 100: 3983–3988.
- Ashley DJB. 1969. The two hit and multiple hit theories of carcinogenesis. Br J Cancer 23: 313–3328.
- Birnie R, Bryce SD, Roome C, Dussupt V, Droop A, Lang SH, Berry PA, Hyde CF, Stower MJ, Maitland NJ, Collins AT. 2008. Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions. Genome Biol 9(5): R83.
- Bodmer W. 2008. Genetic instability is not a requirement for tumor development. Cancer Res 68: 3558–3560.
- Bonnet D, Dick JE. 1997. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3: 730–737.
- Bostwick DG, Leske DA, Qian JQ, Sinha AA. 1995. Prostatic intraepithelial neoplasia and well-differentiated adenocarcinoma maintain an intact basement-membrane. Pathol Res Pract 191(9): 850–855.
- Butel JS. 2000. Viral carcinogenesis: Revelation of molecular mechanisms and etiology of human disease. Carcinogenesis 21(3): 405–426.
- Cairns J. 1975. Mutation selection and the natural history of cancer. Nature 255(5505): 197–200.
- Cairns J. 1998 Mutation and cancer: The antecedents to our studies of adaptive mutation. Genetics 1148: 1433–1440.
- Calabrese P, Tavare S, Shibata D. 2004 Pretumor progression: Clonal evolution of human stem cell populations. Am J Pathol 164: 1337–1346.
- Carpten J, Nupponen N, Isaacs S, Sood R, Robbins C, Xu J, Faruque M, Moses T, Ewing C, Gillanders E, Hu P, Bujnovszky P, Makalowska I, Baffoe-Bonnie A, Faith D, Smith J, Stephan D, Wiley K, Brownstein M, Gildea D, Kelly B, Jenkins R, Hostetter G, Matikainen M, Schleutker J, Klinger K, Connors T, Xiang Y, Wang Z, De Marzo A, Papadopoulos N, Kallioniemi OP, Burk R, Meyers D, Grönberg H, Meltzer P, Silverman R, Bailey-Wilson J, Walsh P, Isaacs W, Trent J. 2002. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet 30(2): 181–184.
- Clegg N, Abbott D, Ferguson C, Coleman R, Nelson PS. 2004. Characterization and comparative analyses of transcriptomes from the normal and neoplastic human prostate. Prostate 60(3): 227–239.
- Collins AT, Maitland NJ. 2006. Prostate cancer stem cells. Eur J Cancer 42(9): 1213–1218.
- Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. 2005. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65(23): 10946–10951.
- Coussens LM, Werb Z. 2002. Inflammation and cancer. Nature 420: 860–867.
- Culig Z, Bartsch G, Hobisch A. 2002. Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth. Mol Cell Endocrinol 197(1–2): 231–238.
- Cunha GR. 1984. Androgenic effects upon prostatic epithelium are mediated via trophic influences from stroma. Prog Clin Biol Res 145: 81–102.
- Cunha GR, Hayward SW, Wang YZ, Ricke WA. 2003 Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer 107(1): 1–10.
- Das D, Shah RB, Imperiale MJ. 2004. Detection and expression of human BK virus sequences in neoplastic prostate tissues. Oncogene 23(42): 7031–7046.
- Das D, Wojno K, Imperiale MJ. 2008. BK virus as a cofactor in the etiology of prostate cancer in its early stages. J Virol 82(6): 2705–2714.
- De Marzo AM, Meeker AK, Epstein JI, Coffey DS. 1998. Prostate stem cell compartments: Expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells. Am J Pathol 153(3): 911–919.
- De Marzo AM, Marchi VL, Epstein JI, Nelson WG. 1999. Proliferative inflammatory atrophy of the prostate: Implications for prostatic carcinogenesis. Am J Pathol 155(6): 1985–1992.
- De Marzo AM, Platz EA, Sutcliffe S, Xu J, Grönberg H, Drake CG, Nakai Y, Isaacs WB, Nelson WG. 2007. Inflammation in prostate carcinogenesis. Nat Rev Cancer 7(4): 256–269.
- Devens BH, Weeks RS, Burns MR, Carlson CL, Brawer MK. 2000. Polyamine depletion therapy in prostate cancer. Prostate Cancer Prostatic Dis 3: 275–279.
- Dong B, Kim S, Hong S, Das Gupta J, Malathi K, Klein EA, Ganem D, Derisi JL, Chow SA, Silverman RH. 2007. An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc Natl Acad Sci 104(5): 1655–1660.
- Draper JS, Smith K, Gokhale P, Moore HD, Maltby E, Johnson J, Meisner L, Zwaka TP, Thomson JA, Andrews PW. 2004. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol 22(1): 53–54.
- Elkahwaji JE, Zhong W, Hopkins WJ, Bushman W. 2006. Chronic bacterial infection and inflammation incite reactive hyperplasia in a mouse model of chronic prostatitis. Prostate 67: 14–21.
- English HF, Santen RJ, Isaacs JT. 1987. Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement. Prostate 11(3): 229–242.
- Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61(5): 759–767.
- Fox JG, Wang TC. 2007. Inflammation, atrophy, and gastric cancer. J Clin Invest 117(1): 60–69.
- Frank SA, Nowak MA. 2003. Developmental predisposition to cancer. Nature 422: 494.
- Franks LM. 1954. Latent carcinoma of the prostate. J Pathol Bacteriol 68: 603–616.
- Gleason DF. 1966. Classification of prostatic carcinomas. Cancer Chemother Rep 50(3): 125–128.
- Goetzl MA, Holzbeierlein JM. 2006. Finasteride as a chemopreventive agent in prostate cancer: Impact of the PCPT on urologic practice. Nat Clin Pract Urol 3(8): 422–429.
- Greaves M. 2007. Darwinian medicine: A case for cancer. Nature Rev Cancer 7(3): 213–221.
- Green CB, Liu WY, Kwok SC. 1990. Cloning and nucleotide sequence analysis of the human beta-microseminoprotein gene. Biochem Biophys Res Commun 167: 1184–1190.
- Han G, Buchanan G, Ittmann M, Harris JM, Yu X, Demayo FJ, Tilley W, Greenberg NM. 2005. Mutation of the androgen receptor causes oncogenic transformation of the prostate. Proc Natl Acad Sci 102(4): 1151–1156.
- Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100: 57–70.
- Haverkos HW. 2004. Viruses, chemicals and co-carcinogenesis. Oncogene 23: 6492–6499.
- Hermans KG, van Marion R, van Dekken H, Jenster G, van Weerden WM, Trapman J. 2006 TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer. Cancer Res 66(22): 10658–10663.
- Hobisch A, Rogatsch H, Hittmair A, Bartsch G, Culig A. 2000. Immunohistochemical localisation of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue. J Pathol 191: 239–244.
- Houghton J, Stoicov C, Nomura S, Rogers AB, Carlson J, Li H, Cai X, Fox JG, Goldenring JR, Wang TC. 2004. Gastric cancer originating from bone marrow-derived cells. Science 306: 1568–1571.
- Hudson DL, Guy AT, Fry P, O'Hare MJ, Watt FM, Masters JR. 2001. Epithelial cell differentiation pathways in the human prostate: Identification of intermediate phenotypes by keratin expression. J Histochem Cytochem 49(2): 271–278.
- Isaacs JT, Coffey DS. 1989. Etiology and disease process of benign prostatic hyperplasia. Prostate suppl 2: 33–50.
- Jacobs EJ, Thun MJ, Bain EB, Rodriguez C, Henley SJ, Calle EE. 2007. A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence. J Natl Cancer Inst 99(8): 608–615.
- Joshua AM, Evans A, Van der Kwast T, Zielenska M, Meeker AK, Chinnaiyan A, Squire JA. 2008. Prostatic preneoplasia and beyond. Biochim Biophys Acta 1785(2): 156–181.
- Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S, Crowley D, Bronson RT, Jacks T. 2005. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121: 823–835.
- Korodi Z, Dillner J, Jellum E, Lumme S, Hallmans G, Thoresen S, Hakulinen T, Stattin P, Luostarinen T, Lehtinen M, Hakama M. 2005. Human papillomavirus 16, 18 and 33 infections and risk of prostate cancer: A Nordic nested case-control study. Cancer Epidemiol Biomarkers Prev 14(12): 2952–2955.
- Krieger JN, Riley DE, Vesella RL, Miner DC, Ross SO, Lange PH. 2000. Bacterial DNA sequences in prostate tissue from patients with prostate cancer and chronic prostatitis. J Urol 164: 1221–1228.
- LaTulippe E, Satagopan J, Smith A, Scher H, Scardino P, Reuter V, Gerald WL. 2002. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res 62(15): 4499–4506.
- Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, Park JK, Fine HA. 2006. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9(5): 391–403.
- Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R. 1997. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275(5308): 1943–1947.
- Litvinov IV, Vander Griend DJ, Antony L, Dalrymple S, De Marzo AM, Drake CG, Isaacs JT. 2006. Androgen receptor as a licensing factor for DNA replication in androgen-sensitive prostate cancer cells. Proc Natl Acad Sci 103(41): 15085–15090.
- Loeb LA, Bielas JH, Beckman RA. 2008 Cancers exhibit a mutator phenotype: Clinical implications. Cancer Res 68: 3551–3556.
- Maitland NJ, Collins AT. 2008. Prostate cancer stem cells. J Clin Oncol 26(17): 2862–2870.
- Maitland NJ, Bryce SD, Stower MJ. 2006. Prostate cancer stem cells: A target for new therapies. Ernst Schering Found Symp Proc 5: 155–179.
- Marker PC, Donjacour AA, Dahiya R, Cunha GR. 2003. Hormonal, cellular, and molecular control of prostatic development. Dev Biol 253: 165–174.
- Massie CE, Adryan B, Barbosa-Morais NL, Lynch AG, Tran MG, Neal DE, Mills IG. 2007. New androgen receptor genomic targets show an interaction with the ETS1 transcription factor. EMBO Rep 8(9): 871–878.
10.1038/sj.embor.7401046 Google Scholar
- McNeal JE. 1980. Anatomy of the prostate: An historical survey of divergent views. Prostate 1: 3–13.
- McNeal JE, Redwine EA, Freiha FS, Stamey TA. 1988. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 12: 897–906.
- Meeker AK, Hicks JL, Iacobuzio-Donahue CA, Montgomery EA, Westra WH, Chan TY, Ronnett BM, De Marzo AM. 2004. Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin Cancer Res 10(10): 3317–3326.
- Mehra R, Tomlins SA, Shen R, Nadeem O, Wang L, Wei JT, Pienta KJ, Ghosh D, Rubin MA, Chinnaiyan AM, Shah RB. 2007. Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer. Mod Pathol 20(5): 538–544.
- Molinaro RJ, Jha BK, Malathi K, Varambally S, Chinnaiyan AM, Silverman RH. 2006. Selection, cloning of poly(rC)-binding protein 2, Raf kinase inhibitor protein RNA activators of 2', 5'-oligoadenylate synthetase from prostate cancer cells. Nucleic Acids Res 34(22): 6684–6695.
- Morrissey C, Vessella RL. 2007. The role of tumor microenvironment in prostate cancer bone metastasis. J Cell Biochem 101(4): 873–886.
- Nakai Y, Nelson WG, De Marzo AM. 2007. The dietary charred meat carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine acts as both a tumor initiator and promoter in the rat ventral prostate. Cancer Res 67(3): 1378–1384.
- Nelson WG, Yegnasubramanian S, Agoston AT, Bastian PJ, Lee BH, Nakayama M, De Marzo AM. 2007. Abnormal DNA methylation, epigenetics, and prostate cancer. Front Biosci 12: 4254–4266.
- O'Brien CA, Pollett A, Gallinger S, Dick JE. 2007. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106–110.
- Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR. 1999. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59(19): 5002–5011.
- Osman I, Drobnjak M, Fazzari M, Ferrara J, Scher HI, Cordon-Cardo C. 1999. Inactivation of the p53 pathway in prostate cancer: Impact on tumor progression. Clin Cancer Res 5(8): 2082–2088.
- Palapattu GS, Meeker A, Harris T, Collector MI, Sharkis SJ, DeMarzo AM, Warlick C, Drake CG, Nelson WG. 2006. Epithelial architectural destruction is necessary for bone marrow derived cell contribution to regenerating prostate epithelium. J Urol 176(2): 813–818.
- Park SY, Yu X, Ip C, Mohler JL, Bogner PN, Park YM. 2007. Peroxiredoxin 1 interacts with androgen receptor and enhances its transactivation. Cancer Res 67(19): 9294–9303.
- Pawelek JM, Chakraborty AK. 2008. Fusion of tumour cells with bone marrow-derived cells: A unifying explanation for metastasis. Nature Rev Cancer 8: 377–386.
- Pienta KJ, Abate-Shen C, Agus DB, Attar RM, Chung LW, Greenberg NM, Hahn WC, Isaacs JT, Navone NM, Peehl DM, Simons JW, Solit DB, Soule HR, Vandyke TA, Weber MJ, Wu L, Vessella RL. 2008. The current state of preclinical prostate cancer animal models. Prostate 68(6): 629–639.
- Postma R, Schröder FH, van der Kwast TH. 2005. Atrophy in prostate needle biopsy cores and its relationship to prostate cancer incidence in screened men. Urology 65(4): 745–749.
- Potten CS, Grant HK. 1998. The relationship between ionizing radiation-induced apoptosis and stem cells in the small and large intestine. Br J Cancer 78(8): 993–1003.
- Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R. 2007. Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111–115.
- Richardson GD, Robson CN, Lang SH, Neal DE, Maitland NJ, Collins AT. 2004. CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 117(Pt 16): 3539–3545.
- Roche PJ, Hoare SA, Parker MG. 1992. A consensus DNA-binding site for the androgen receptor. Mol Endocrinol 6: 2229–2235.
- Scadden DT. 2006. The stem cell niche as an entity of action. Nature 441: 1075–1079.
- Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB. 2003. Identification of a cancer stem cell in human brain tumors. Cancer Res 63(18): 5821–5828.
- Sjöblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE. 2006. The consensus coding sequences of human breast and colorectal cancers. Science 314(5797): 268–274.
- Taplin ME. 2007. Drug insight: Role of the androgen receptor in the development and progression of prostate cancer. Nat Clin Pract Oncol 4(4): 236–244.
- Tomlinson IP, Novelli MR, Bodmer WF. 1996. The mutation rate and cancer. Proc Natl Acad Sci 93: 14800–14803.
- Tran CP, Lin C, Yamashiro J, Reiter RE. 2002. Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells. Mol Cancer Res 1: 113–121.
- Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, Klein EA, Malathi K, Magi-Galluzzi C, Tubbs RR, Ganem D, Silverman RH, DeRisi JL. 2006. Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2(3): e25.
- Van Leenders GJ, Aalders TW, Hulsbergen-van de Kaa CA. 2001. Expression of basal cell keratins in human prostate cancer metastases and cell lines. J Pathol 195(5): 563–570.
- Verrijdt G, Haelens A, Claessens F. 2003. Selective DNA recognition by the androgen receptor as a mechanism for hormone-specific regulation of gene expression. Mol Genet Metab 78: 175–178.
- Wei C, Guomin W, Yujun L, Ruizhe Q. 2007. Cancer stem-like cells in human prostate carcinoma cells DU145: The seeds of the cell line. Cancer Biol Ther 6: 763–768.
- Zambrano A, Kalantari M, Simoneau A, Jensen JL, Villarreal LP. 2002. Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections. Prostate 53: 263–276.
- Zhou A, Hassel BA, Silverman RH. 1993. Expression cloning of 2-5A-dependent RNAase: A uniquely regulated mediator of interferon action. Cell 72: 753–765.
- zur Hausen H. 2002. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer 2(5): 342–350.